This inventor holds 1 USPTO granted patent. Top assignee: Crown Bioscience, Inc. (Taicang). Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Henry Li - Innovator in Cancer Treatment
Introduction
Henry Li is a prominent inventor based in Taicang, China. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the detection and treatment of specific genetic markers associated with cancer.
Latest Patents
Henry Li holds a patent for the HNF4G-RSPO2 fusion gene and its use in the treatment of cancer. This patent outlines methods for detecting the fusion gene of HNF4G and RSPO2 in nucleic acid-containing samples. It also includes a primer set, a probe set, and a kit for detecting the fusion gene. Additionally, the patent provides animal models for human diseases that are positive for the fusion gene. The methods described in the patent aim to assess and identify agents effective against the fusion gene or related human diseases.
Career Highlights
Henry Li is associated with Crown Bioscience, Inc., where he continues to advance his research in cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies for cancer patients.
Collaborations
Henry collaborates with Jie Cai, contributing to the innovative research environment at Crown Bioscience, Inc. Their combined efforts aim to enhance the understanding and treatment of cancer.
Conclusion
Henry Li's contributions to cancer research through his patent on the HNF4G-RSPO2 fusion gene exemplify the importance of innovation in medical science. His work holds promise for improving treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile